Purchase Order 75F40119P10205

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to SB Drug Discovery LIMITED, a for-profit organization, to provide cultured cells stably expressing the human form of the NAV1.5 channel protein for use in in vitro electrophysiology and ion channel pharmacology projects. The contract has a ceiling value of $24,000.00 and was awarded on June 28, 2016 with a completion date of September 24, 2016. The award was not associated with any...

This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Nanion Technologies Inc., a for-profit corporation that provides scientific instruments and services related to ion channel drug discovery. The $114,374.00 firm fixed-price contract is for the delivery of a Patch Clamp Rig (Port-A-Patch) and a Bilayer Recording Station (Orbit Mini) to support the National Institute of Neurological Disorders and Stroke's...

This is a $68,500 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to The Jackson Laboratory, a nonprofit biomedical research institution located in Bar Harbor, Maine. The contract is for a single in vivo pharmacokinetic (PK) study of antibody-lectin conjugates to determine the sera half-life of laboratory compounds. The original solicitation was issued by the Eunice Kennedy Shriver National Institute of Child Health and...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $35,025 firm fixed price purchase order to Codex Biosolutions Inc. under a non-competitive solicitation. Codex will generate a stable P/Q type calcium channel CaV2.1 cell line by cloning specified channel proteins into HEK293 cells and introducing an additional channel to control calcium flux, as described in the attached statement of work. The one-year contract has a period of performance from...

The National Institutes of Health's National Institute on Deafness and Other Communication Disorders awarded a $10,079 firm fixed price purchase order to Charles River Laboratories, Inc. for amplifying shuttle vectors and adeno-associated virus packaging of distinct mechanotransduction channels. Charles River will perform large scale adeno-associated virus packaging and purification services at its Wilmington, Massachusetts facility to support the agency's research into mechanotransduction,...

The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $40,505 firm-fixed-price purchase order to Charles River Laboratories, Inc. to perform characterization testing of Pichia master and working cell banks. This work supports ongoing research at the Laboratory of Malaria Immunology and Vaccinology to develop a malaria transmission-blocking vaccine candidate. The testing will demonstrate the identity, purity,...

This is a firm fixed-price contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Viralgen Vector Core SL, a for-profit organization located in Spain. The contract, valued at $533,124.00, is for the extension of stability testing up to 48 months and additional analytical testing to support the compatibility of the MMA-101 adeno-associated virus gene therapy candidate targeting methyl malonic acidemia. The contract is not set aside for any specific business...

This is a $8,572.04 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to The Jackson Laboratory, a nonprofit biomedical research institution. The contract is to acquire 3XTG-AD mice, which are a genetically engineered mouse model used in Alzheimer's disease research. The Jackson Laboratory is a well-established provider of specialized research animals and other services to federal agencies like the NIH, DoD, and CDC to support their...

This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Lonza Walkersville, Inc., a foreign-owned, for-profit manufacturer of biological materials and laboratory equipment. The $24,220.00 contract is for the provision of a Nucleofector Cell Transfection Device, brand name or equal, to support the VA's biomedical research and development efforts. The contract has no set-aside designation and is part of a larger $10 million Blanket Purchase Agreement (BPA)...

This purchase order awarded to Rutgers, The State University on March 3, 2009, provides 20 human lymphoblast cell lines required for an ongoing pharmacogenetic research project conducted collaboratively between the university's Biomarker Lab and Dr. Francis McMahon's Genetic Lab. The award, valued at $4,000 firm fixed price, was made to Rutgers as a sole source supplier, indicating the university possesses unique capabilities to provide these specialized biological materials. The contract was...